Cell Line Development Market Size

Cell Line Development Market Size

Cell Line Development Market size was valued at USD 5.8 billion in 2023 growing at a CAGR of 10.3% between 2024 and 2032. One of the primary drivers for the growth is the surging global prevalence of cancer owing to adoption of sedentary lifestyle, lack of physical exercise, consumption of harmful substances such as alcohol, tobacco, exposure to environmental pollutants and radiation.

To get key market trends

  Download Free Sample

 For instance, as per the report of the World Health Organization and International Agency for Research on Cancer (IARC) in February 2024, it has been reported that in 2022, there were an estimated 20 million new cancer cases and 9.7 million deaths. The estimated number of people who were alive within 5 years following a cancer diagnosis was 53.5 million.

Also, about 1 in 5 people develop cancer in their lifetime, approximately 1 in 9 men and 1 in 12 women died from the disease. Thus, the rising incidence of cancer has created a greater need for early and accurate diagnosis of disease along with rising demand for the development of novel drug therapeutics which are the factors driving the demand for cell line products. Moreover, higher demand for vaccines and increasing awareness pertaining to monoclonal antibodies will accelerate the overall industry progress.

Cell line development (CLD) is a method that is utilized in a range of research and drug development and production applications such as identifying therapeutic targets and producing biologic drugs. The method starts with the selection of host cells and the most used host cell is HEK293 cells. Further, cell line development requires the discovery of clones derived from single cells that produce high and consistent levels of the target therapeutic protein.